Poop pills to fight cancer drug side effects?
NCT ID NCT04163289
Summary
This study is testing if a fecal microbiota transplant (FMT), which transfers healthy gut bacteria from a donor, can help patients with advanced kidney cancer better tolerate a powerful two-drug immunotherapy combination. The goal is to reduce severe side effects so patients can stay on their cancer treatment longer. Researchers will give the FMT to 20 patients before and during their immunotherapy to see if it is safe and helps prevent toxic reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Regional Cancer Program of the Lawson Health Research Institute
London, Ontario, N6A 5W9, Canada
Conditions
Explore the condition pages connected to this study.